ZHAO Z, HU X, ZHANG Y, LIU D. Cardiovascular and safety events of PCSK9 inhibitors in statin-treated patients with cardiovascular risk: A Systematic Review and Meta-Analysis. J Pharm Pharm Sci [Internet]. 2020 Oct. 31 [cited 2024 Oct. 12];23:422-36. Available from: https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/31197